Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma

Health-related quality of life supersedes other psychosocial predictors of long-term survival in cancer patients undergoing radiotherapy

(2012) Susanne Sehlen et al.   ACTA ONCOLOGICA

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

(2011) Y. Brandberg et al.   EUROPEAN JOURNAL OF CANCER

Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial

(2011) Johan Hansson et al.   LANCET ONCOLOGY

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008

(2009) Ali Montazeri   Health and Quality of Life Outcomes

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

(2009) Chantal Quinten et al.   LANCET ONCOLOGY

The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials

(2008) Carolyn C. Gotay et al.   JOURNAL OF CLINICAL ONCOLOGY